Clinical Trial Update: Clinical Trial of the PfSPZ Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of the PfSPZ malaria vaccine by Sanaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Plasmodium Falciparum | Phase 1 | Status: COMPLETED